https://www.theblockcrypto.com/post/124396/coinbase-is-looking-at-support-for-third-party-defi-apps-on-its-platform-says-cfo
SVB Leerink Downgrades Arena Pharmaceuticals to Market Perform, Lowers Price Target to $100
SVB Leerink analyst Joseph Schwartz downgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Outperform to Market Perform and lowers the price target from $112 to $100.